Tolonen Matti, Vikatmaa Pirkka
From the Department of Abdominal Surgery (M.T.), HUS Abdominal Center; and Department of Vascular Surgery (P.V.), Abdominal Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
J Trauma Acute Care Surg. 2025 Aug 1;99(2):151-161. doi: 10.1097/TA.0000000000004585. Epub 2025 Mar 20.
Acute mesenteric ischemia (AMI) is associated with high mortality rates. There are multiple challenges to establishing an accurate early diagnosis and providing state-of-the-art care for AMI patients. A high index of suspicion is key for early diagnosis. Once suspicion is raised, a triphasic computed tomography angiography is the essential diagnostic tool. Avoiding delays, using hybrid operating rooms and contemporary revascularization techniques for arterial occlusive AMI, can significantly improve the prognosis. Regional health care systems should be developed to direct AMI patients into centers with sufficient capabilities for providing all aspects of care at all hours. The acute care surgeon has a central role in performing laparotomies and bowel resections when needed and coordinating the management flow in close collaboration with vascular surgeons and interventional radiologists for prompt and effective revascularization. A significant share of patients with an arterial occlusive AMI can be managed by endovascular revascularization without the need for a laparotomy. There are no reliable tools for predicting transmural bowel necrosis, and individual assessment and clinical experience are very important in decision-making when choosing between laparotomy and close observation. During laparotomy, an atherosclerotic occlusion at the root of the superior mesenteric artery can be stented by using a retrograde open mesenteric or percutaneous approach, and surgical bypass is seldom needed. Using hospital-specific management pathways is very useful for the standardization of care in arterial occlusive AMI. In venous AMI, systemic anticoagulation is sufficient in most cases. In patients whose symptoms do not resolve, there are various options for endovascular and surgical revascularization. In nonocclusive mesenteric ischemia, prevention by maintaining sufficient abdominal perfusion pressure is key. High-level evidence is scarce, but with current knowledge, the prognosis of AMI patients has plenty of room for improvement.
急性肠系膜缺血(AMI)与高死亡率相关。对AMI患者进行准确的早期诊断并提供先进的治疗存在诸多挑战。高度的怀疑指数是早期诊断的关键。一旦产生怀疑,三相计算机断层扫描血管造影是必不可少的诊断工具。避免延误,使用杂交手术室以及采用当代血管重建技术治疗动脉闭塞性AMI,可显著改善预后。应发展区域医疗保健系统,以便将AMI患者引导至有能力随时提供全方位护理的中心。急性外科医生在必要时进行剖腹手术和肠切除,并与血管外科医生和介入放射科医生密切合作协调管理流程,以实现迅速有效的血管重建,发挥着核心作用。相当一部分动脉闭塞性AMI患者可通过血管内血管重建进行治疗,无需剖腹手术。目前尚无可靠的工具来预测透壁性肠坏死,在选择剖腹手术和密切观察之间进行决策时,个体评估和临床经验非常重要。在剖腹手术期间,可通过逆行开放肠系膜或经皮途径对上肠系膜动脉根部的动脉粥样硬化闭塞进行支架置入,很少需要进行外科搭桥手术。使用医院特定的管理路径对动脉闭塞性AMI的护理标准化非常有用。在静脉性AMI中,大多数情况下全身抗凝就足够了。对于症状未缓解的患者,有多种血管内和外科血管重建的选择。在非闭塞性肠系膜缺血中,通过维持足够的腹部灌注压进行预防是关键。高级别证据很少,但就目前的知识而言,AMI患者的预后仍有很大的改善空间。